qPharmetra
qPharmetra is a US-domiciled pharmacometrics and clinical pharmacology consulting firm, founded in 2010, that provides population PK/PD modeling, dose selection, and regulatory submission support to pharmaceutical and biotechnology drug developers across the US and Europe.
- Company typePrivate
- Founded2010
- HeadquartersCary, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What qPharmetra does
qPharmetra is a privately held, US-incorporated (qPharmetra LLC, domiciled in Cary, North Carolina) professional services firm founded in July 2010 that provides pharmacometric analysis, clinical pharmacology consulting, and supporting custom software tools to pharmaceutical and biotechnology companies developing new drugs. Its work centers on mathematical modeling of drug-human interactions — population PK, PK/PD, non-compartmental analysis, drug-disease modeling, and clinical trial simulations — to inform dose selection from first-in-human through Phase 3 and to support regulatory submissions, briefing documents, and NDA packages. The firm operates across three formal business units (Pharmacometrics, Clinical Pharmacology, and Customized Software) and serves clients primarily in the US and Europe, with consultants distributed across Sweden, Germany, the Netherlands, Spain, Belgium, and the United States.
The technology stack is built on NONMEM for population PK/PD modeling and the R programming environment, extended by a portfolio of open-source R packages — qptools for pharmacometric analysis reporting, qpNCA for non-compartmental analysis, yamlet for metadata curation, and Argo, a Docker-based CLI that locks R environments for reproducibility across Windows, Linux, and macOS. Deliverables are produced under a documented Quality System of 15+ Standard Operating Procedures and a standardized qpAnalysis methodology that institutionalizes workflow consistency across consultants. The firm also offers Shiny application development and hosting, allowing clients to interact with analysis systems via web pages.
Commercially, qPharmetra is a project-based, quote-based B2B consulting practice with no publicly disclosed pricing or revenue figures. It is founder/partner-owned with no known external institutional investors, scaled to over 30 PhD-level scientists (more than 75% with PhDs) located across the US and Europe. Distribution is direct enterprise engagement led by senior consultants, supported by LinkedIn, the company website, peer-reviewed publications, and participation at specialized conferences such as the Pharmacometrics Network Benelux meeting. Mutual referral partnerships with PKxpert AB, Pharma Consulting Aachen, and eScienceQPS extend coverage into toxicokinetics, regulatory CTD preparation, and non-clinical PK consulting.
qPharmetra firmographics
Firmographics- Name
- qPharmetra
- Legal name
- qPharmetra LLC.
- Website
- https://qpharmetra.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- qPharmetra is a US-domiciled pharmacometrics and clinical pharmacology consulting firm, founded in 2010, that provides population PK/PD modeling, dose selection, and regulatory submission support to pharmaceutical and biotechnology drug developers across the US and Europe.
- Ownership category
- akta.pro rank
qPharmetra industry classification
Industry- Product category
- Pharmacometric and Clinical Pharmacology Consulting
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Pharmacology & Pharmacometrics (Modeling & Simulation) (HLAIALAG)
- akta.pro secondary industries
- Quality Management Systems (QMS) & GxP Documentation (HLAGAKAD), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where qPharmetra is headquartered
LocationHeadquarters
- HQ city
- Cary
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
qPharmetra business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Pharmacometric Consulting Services: Project-based consulting engagements providing pharmacometric analysis, clinical pharmacology consulting, and regulatory submission support to pharmaceutical and biotech companies developing drugs.
- Custom Software Tools: Development and support of open source software tools (qptools, qpNCA, Argo, yamlet) that enable automated data handling, analysis, and reporting workflows.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
qPharmetra product offering
Product offeringCore offering
qPharmetra provides pharmacometric analysis, clinical pharmacology consulting, and custom software tools to drug companies developing new medicines. Services include population PK/PD modeling, non-compartmental analysis, drug-disease modeling, dose selection from First-In-Human through Phase 3, clinical pharmacology plans, bioequivalence, drug-drug interaction and thorough QT studies, and regulatory submission support (NDA and briefing documents), delivered through a standardized qpAnalysis process backed by a Quality System of 15+ SOPs.
Product overview
qPharmetra offers pharmacometric analysis, clinical pharmacology consulting, and custom software tools organized into three business units. The software portfolio includes open-source R packages—qptools (pharmacometric analysis toolkit), qpNCA (noncompartmental analysis), yamlet (metadata curation), and Argo (R environment reproducibility)—plus Shiny application development and hosting services. The consulting services encompass pharmacometric modeling (population PK, PK/PD, drug-disease modeling, clinical trial simulation), clinical pharmacology consulting (dose selection, regulatory submissions, special population studies), and a Quality System built on Standard Operating Procedures and Best Practices. The qpAnalysis standardized approach enables clients to benefit from institutional knowledge and quality assurance processes.
Differentiator
Problem solved
Functional benefit
Products and services
- qptools
- qpNCA
- Argo
- yamlet
- Shiny Application Hosting and Development Services Development services and hosting for Shiny applications that allow users to interact with analysis systems through web pages, enabling real-time exploration of different scenarios with secure web deployment. Targeted at clients who want interactive web-based access to pharmacometric analyses.
- qpAnalysis A standardized consulting approach providing a disciplined and transparent process with clear modeling methodology, complete documentation, and compelling reports and graphics for pharmacometric projects. Delivered to pharmaceutical and biotech clients as part of qPharmetra's pharmacometrics engagements.
- Quality System A comprehensive quality management system comprising 15+ Standard Operating Procedures and Best Practices that ensures high-quality, reliable analyses, models, and reports through documented processes and quality control. Provided to clients as part of pharmacometrics and clinical pharmacology engagements to deliver regulatory-ready outputs.
- Pharmacometrics Consulting Mathematical and statistical modeling of biology, pharmacology, disease, and physiology to describe and quantify drug-human interactions, including population PK, PK/PD modeling, non-compartmental analysis, drug-disease modeling, and clinical trial simulations. Delivered to pharmaceutical and biotechnology companies developing new drugs.
- Clinical Pharmacology Consulting Clinical pharmacology strategy and consulting including dose selection from First-In-Human through Phase 3, clinical pharmacology plan development, bioequivalence studies, food effect, drug-drug interaction and thorough QT studies, and regulatory submission support. Provided to pharmaceutical and biotech drug developers.
Quantifiable outcome
- Multiple successful NDA submissions in neuroscience and oncology therapeutic areas
Companies that use qPharmetra
Customer profileSegments2 records
Ideal customer profiles2 records
qPharmetra technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
qPharmetra partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- PKxpert ABminorProvides consultancy services and expert knowledge in Pharmacokinetics and Toxicokinetics (TK) Analysis using Phoenix WinNonlin, TK Analysis according to GLP, Drug Metabolism, Regulatory ADME studies, PKPD Simulations and Predictions, Preclinical Research & Development Project Management.
- Pharma Consulting AachenminorGroup of drug development experts specialized in designing strategies and devising, accompanying, and evaluating clinical and preclinical investigations; preparation, review, and evaluation of complete documentations (CTD) for pharmaceutical approval procedures; regulatory consulting and guidance at regulatory submissions.
- eScienceQPSminorOffers scientific consulting and support services in non-clinical and clinical pharmacokinetics, pharmacology and pharmacometrics, PK lead in drug development programs and research projects, scientific writing, coaching and teaching activities.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
qPharmetra competitors and assessment
Company assessmentEmerging players
- PharSafer: PharSafer is a drug safety and pharmacovigilance services provider with clinical pharmacology expertise. It is an adjacent peer in the pharma consulting services space with partial overlap in regulatory submission support work.
- Institute for Clinical Pharmacodynamics (ICPD): ICPD provides clinical pharmacology and PK/PD consulting services, including exposure-response analyses and regulatory submission support. It is a specialized peer with overlapping service offerings in clinical pharmacology consulting.
- Pumas-AI: Pumas-AI develops the Pumas pharmacometrics platform built on Julia, providing modeling and simulation software for pharma and academic users. It represents an emerging software-first competitor to qPharmetra's R-based tooling and consulting model.
- Lixoft: Lixoft developed the MonolixSuite for nonlinear mixed-effects modeling and was acquired by Simulations Plus. It represents a peer in the pharmacometrics software ecosystem that qPharmetra's open-source tools (qptools, qpNCA) compete against or complement.
Direct peers
- Certara: Certara is the largest dedicated pharmacometrics and biosimulation company, offering software (Phoenix WinNonlin, Simcyp) and consulting services to pharma and biotech. It directly competes with qPharmetra in pharmacometric modeling, clinical pharmacology consulting, and regulatory submission support, but at significantly greater scale and with proprietary software.
- Pharmetheus: Pharmetheus is a Sweden-based pharmacometrics consulting firm founded by Uppsala University alumni, offering population PK/PD modeling, clinical trial simulations, and regulatory science services. It is a close geographic and methodological peer to qPharmetra, sharing the Uppsala pharmacometrics heritage.
- Cognigen: Cognigen was a pharmacometrics consulting firm acquired by Simulations Plus, providing population PK/PD modeling and regulatory submission support. It is a direct historical peer to qPharmetra in the boutique pharmacometrics consulting space.
- Metrum Research Group: Metrum Research Group is a US-based pharmacometrics and clinical pharmacology consulting firm offering population PK/PD modeling, model-based drug development, and regulatory submission support. It is a direct boutique competitor to qPharmetra with similar service offerings and target clients.
- Simulations Plus: Simulations Plus provides modeling and simulation software (GastroPlus, MonolixSuite) and services for pharmacokinetics, pharmacodynamics, and quantitative systems pharmacology. It competes with qPharmetra in both consulting and software, having acquired Cognigen and Lixoft to expand pharmacometrics capabilities.
- LAP&P Consultants: LAP&P Consultants is a Netherlands-based clinical pharmacology and pharmacokinetics consulting firm, providing bioanalysis, PK/PD modeling, and regulatory support. It shares the European footprint and clinical pharmacology focus with qPharmetra.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
qPharmetra social profiles
Digital presenceqPharmetra compliance and trust
Trust signalCompliance1 record
qPharmetra financial estimates
Financial estimateRevenue estimate
Valuation estimate
qPharmetra leadership team
Management profileNumber of profiles
Profiles5 records
qPharmetra funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
qPharmetra M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about qPharmetra
What does qPharmetra do?
qPharmetra provides pharmacometric analysis, clinical pharmacology consulting, and custom software tools to drug companies developing new medicines. Services include population PK/PD modeling, non-compartmental analysis, drug-disease modeling, dose selection from First-In-Human through Phase 3, clinical pharmacology plans, bioequivalence, drug-drug interaction and thorough QT studies, and regulatory submission support (NDA and briefing documents), delivered through a standardized qpAnalysis process backed by a Quality System of 15+ SOPs.
Is qPharmetra a public or private company?
qPharmetra is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was qPharmetra founded?
qPharmetra was founded in 2010. It employs 11 to 50 people.
Where is qPharmetra based?
qPharmetra is headquartered in Cary, United States, in the North America region.
How does qPharmetra make money?
Two revenue lines are on record. Pharmacometric Consulting Services are the primary driver. The others are custom Software Tools.
Who are qPharmetra's main competitors?
Emerging players on record are PharSafer, Institute for Clinical Pharmacodynamics (ICPD), Pumas-AI and Lixoft. Direct peers are Certara, Pharmetheus, Cognigen, Metrum Research Group, Simulations Plus and LAP&P Consultants.
Does qPharmetra have an API?
No public API is recorded for qPharmetra.
What industry is qPharmetra in?
qPharmetra's product category is Pharmacometric and Clinical Pharmacology Consulting. Its primary akta.pro industry code is HLAIALAG, Clinical Pharmacology & Pharmacometrics (Modeling & Simulation), with a secondary code of HLAGAKAD, Quality Management Systems (QMS) & GxP Documentation. Its NAICS code is 54171 and its SIC code is 8731.